投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。
VHTの2022年Q4（12月）の配当金が発表されました。
2022年Q4（12月）の配当実績は$0.9796＄でした。（ブログ内では0.98＄と記載しています）
2021年Q4は$0.81200＄（ブログ内では0.81と記載）、前年同期比より19.4％増配、前年度比では108.3％になりました。
Q３では厳しい結果でしたが、Q4に巻き返しました。
結果、前年度比よりプラスで着地しました。
参考サイト
VHTの投資成績を詳しく知りたい人はバンガード社・Bloombergのウエイブサイトを参考にしてください。
あわせて読みたい
Bloomberg.co.jp
VHT 銘柄 – ﾊﾞﾝｶﾞｰﾄﾞ･ﾍﾙｽｹｱETF 投資信託（ファンド）情報 日中および比較チャート、テクニカル分析、トレンドなどのﾊﾞﾝｶﾞｰﾄﾞ･ﾍﾙｽｹｱETF (VHT – ETF)の最新価格やパフォーマンスをご覧ください。
2022年Q4配当成績一覧表 あわせて読みたい
あわせて読みたい
【2022年Q４】今年のVYMは最高な結果でした 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VYMの2022年Q4（12月）の配当は0.9745＄でした。（ブログ…
あわせて読みたい
【2022年×VT】今年最後の配当と成績を振り返る 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VTの2022年Q4（12月）の配当金が発表されました。 2022年Q…
ぐりっとここからは2022年Q4をこれからも更新していきます。
目次
VHT概要
銘柄名：Vanguard Health Care ETF
銘柄構成数：416
運用会社：バンガード社
設定日：2004年1月26日
経費率：年率0.10％
配当利回り：1.46％（2022/9/27）
ベンチマーク：MSCI USインベスタブル・マーケット・ヘルスケア・インデックス
（MSCI US Investable Market Health Care 25/50 Index ）
・年初来リターン：-15.29％（2022/12/17）
・4半期末」-4.74％（2022/12/17）
・1年：-8.42％（2022/12/17）
構成銘柄
| 順位 | 構成銘柄 | 構成比率 |
| 1 | UnitedHealth Group Incorporated | 8.56% |
| 2 | Johnson & Johnson | 7.81% |
| 3 | Eli Lilly and Company | 5.00% |
| 4 | AbbVie, Inc. | 4.76% |
| 5 | Pfizer Inc. | 4.70% |
| 6 | Merck & Co., Inc. | 4.66% |
| 7 | Thermo Fisher Scientific Inc. | 3.67% |
| 8 | Danaher Corporation | 3.16% |
| 9 | Abbott Laboratories | 3.15% |
| 10 | Bristol-Myers Squibb Company | 2.86% |
| 11 | Amgen Inc. | 2.56% |
| 12 | CVS Health Corporation | 2.23% |
| 13 | Elevance Health, Inc. | 2.14% |
| 14 | Medtronic Plc | 1.75% |
| 15 | Gilead Sciences, Inc. | 1.75% |
| 16 | Cigna Corporation | 1.68% |
| 17 | Intuitive Surgical, Inc. | 1.61% |
| 18 | Vertex Pharmaceuticals Incorporated | 1.35% |
| 19 | Regeneron Pharmaceuticals, Inc. | 1.35% |
| 20 | Stryker Corporation | 1.33% |
| 21 | Zoetis, Inc. Class A | 1.20% |
| 22 | Becton, Dickinson and Company | 1.19% |
| 23 | Humana Inc. | 1.16% |
| 24 | Boston Scientific Corporation | 1.08% |
| 25 | Moderna, Inc. | 0.98% |
| 26 | HCA Healthcare Inc | 0.92% |
| 27 | McKesson Corporation | 0.92% |
| 28 | Centene Corporation | 0.83% |
| 29 | Edwards Lifesciences Corporation | 0.80% |
| 30 | Agilent Technologies, Inc. | 0.77% |
| 31 | DexCom, Inc. | 0.76% |
| 32 | Biogen Inc. | 0.74% |
| 33 | IQVIA Holdings Inc | 0.68% |
| 34 | IDEXX Laboratories, Inc. | 0.59% |
| 35 | Illumina, Inc. | 0.57% |
| 36 | ResMed Inc. | 0.56% |
| 37 | Mettler-Toledo International Inc. | 0.55% |
| 38 | Baxter International Inc. | 0.48% |
| 39 | Veeva Systems Inc Class A | 0.45% |
| 40 | AmerisourceBergen Corporation | 0.44% |
| 41 | Zimmer Biomet Holdings, Inc. | 0.42% |
| 42 | Alnylam Pharmaceuticals, Inc | 0.42% |
| 43 | Horizon Therapeutics Public Limited Company | 0.37% |
| 44 | Cardinal Health, Inc. | 0.36% |
| 45 | Laboratory Corporation of America Holdings | 0.36% |
| 46 | Insulet Corporation | 0.35% |
| 47 | Waters Corporation | 0.35% |
| 48 | Molina Healthcare, Inc. | 0.33% |
| 49 | Hologic, Inc. | 0.32% |
| 50 | BioMarin Pharmaceutical Inc. | 0.31% |
| 51 | STERIS Plc | 0.31% |
| 52 | Quest Diagnostics Incorporated | 0.30% |
| 53 | PerkinElmer, Inc. | 0.29% |
| 54 | West Pharmaceutical Services, Inc. | 0.29% |
| 55 | ABIOMED, Inc. | 0.29% |
| 56 | Seagen, Inc. | 0.28% |
| 57 | Cooper Companies, Inc. | 0.26% |
| 58 | Royalty Pharma Plc Class A | 0.26% |
| 59 | Incyte Corporation | 0.25% |
| 60 | Avantor, Inc. | 0.25% |
| 61 | Align Technology, Inc. | 0.24% |
| 62 | Viatris, Inc. | 0.22% |
| 63 | Bio-Techne Corporation | 0.22% |
| 64 | United Therapeutics Corporation | 0.21% |
| 65 | Neurocrine Biosciences, Inc. | 0.20% |
| 66 | Charles River Laboratories International, Inc. | 0.19% |
| 67 | Henry Schein, Inc. | 0.18% |
| 68 | Teleflex Incorporated | 0.18% |
| 69 | Jazz Pharmaceuticals Public Limited Company | 0.16% |
| 70 | Sarepta Therapeutics, Inc. | 0.16% |
| 71 | Repligen Corporation | 0.16% |
| 72 | Bio-Rad Laboratories, Inc. Class A | 0.15% |
| 73 | Shockwave Medical, Inc. | 0.15% |
| 74 | Universal Health Services, Inc. Class B | 0.14% |
| 75 | Catalent Inc | 0.14% |
| 76 | Acadia Healthcare Company, Inc. | 0.14% |
| 77 | U.S. Dollar | 0.13% |
| 78 | Exact Sciences Corporation | 0.13% |
| 79 | Halozyme Therapeutics, Inc. | 0.13% |
| 80 | Chemed Corporation | 0.13% |
| 81 | Penumbra, Inc. | 0.13% |
| 82 | NovoCure Ltd. | 0.12% |
| 83 | Masimo Corporation | 0.12% |
| 84 | Bruker Corporation | 0.12% |
| 85 | Inspire Medical Systems, Inc. | 0.12% |
| 86 | Organon & Co. | 0.11% |
| 87 | DENTSPLY SIRONA, Inc. | 0.11% |
| 88 | Karuna Therapeutics, Inc. | 0.11% |
| 89 | Encompass Health Corporation | 0.10% |
| 90 | Globus Medical Inc Class A | 0.10% |
| 91 | Envista Holdings Corp. | 0.09% |
| 92 | Exelixis, Inc. | 0.09% |
| 93 | Elanco Animal Health, Inc. | 0.09% |
| 94 | AMN Healthcare Services, Inc. | 0.09% |
| 95 | HealthEquity Inc | 0.09% |
| 96 | Medpace Holdings, Inc. | 0.09% |
| 97 | Ionis Pharmaceuticals, Inc. | 0.09% |
| 98 | Ensign Group, Inc. | 0.08% |
| 99 | Guardant Health, Inc. | 0.08% |
| 100 | LHC Group, Inc. | 0.08% |
| 101 | Tenet Healthcare Corporation | 0.08% |
| 102 | Intra-Cellular Therapies, Inc. | 0.08% |
| 103 | Teladoc Health, Inc. | 0.08% |
| 104 | Azenta, Inc. | 0.08% |
| 105 | QuidelOrtho Corporation | 0.07% |
| 106 | Apellis Pharmaceuticals, Inc. | 0.07% |
| 107 | Haemonetics Corporation | 0.07% |
| 108 | Option Care Health Inc | 0.07% |
| 109 | Perrigo Co. Plc | 0.07% |
| 110 | Lantheus Holdings Inc | 0.07% |
| 111 | Natera, Inc. | 0.07% |
| 112 | Integra LifeSciences Holdings Corporation | 0.07% |
| 113 | Merit Medical Systems, Inc. | 0.07% |
| 114 | Alkermes Plc | 0.07% |
| 115 | CRISPR Therapeutics AG | 0.07% |
| 116 | DaVita Inc. | 0.07% |
| 117 | Premier, Inc. Class A | 0.07% |
| 118 | Cytokinetics, Incorporated | 0.06% |
| 119 | Syneos Health, Inc. Class A | 0.06% |
| 120 | agilon health inc | 0.06% |
| 121 | Neogen Corporation | 0.06% |
| 122 | Mirati Therapeutics Inc. | 0.06% |
| 123 | Intellia Therapeutics, Inc. | 0.06% |
| 124 | iRhythm Technologies, Inc. | 0.05% |
| 125 | Doximity, Inc. Class A | 0.05% |
| 126 | Arrowhead Pharmaceuticals, Inc. | 0.05% |
| 127 | ICU Medical, Inc. | 0.05% |
| 128 | Inari Medical, Inc. | 0.05% |
| 129 | Prestige Consumer Healthcare Inc | 0.05% |
| 130 | LivaNova Plc | 0.05% |
| 131 | Amedisys, Inc. | 0.05% |
| 132 | 10x Genomics Inc Class A | 0.05% |
| 133 | Blueprint Medicines Corp. | 0.05% |
| 134 | Denali Therapeutics Inc. | 0.05% |
| 135 | Tandem Diabetes Care, Inc. | 0.05% |
| 136 | Progyny, Inc. | 0.05% |
| 137 | Axonics, Inc. | 0.04% |
| 138 | PTC Therapeutics, Inc. | 0.04% |
| 139 | Select Medical Holdings Corporation | 0.04% |
| 140 | Enovis Corporation | 0.04% |
| 141 | Beam Therapeutics, Inc. | 0.04% |
| 142 | Amicus Therapeutics, Inc. | 0.04% |
| 143 | CONMED Corporation | 0.04% |
| 144 | Patterson Companies Incorporated | 0.04% |
| 145 | BioCryst Pharmaceuticals, Inc. | 0.04% |
| 146 | Insmed Incorporated | 0.04% |
| 147 | Integer Holdings Corporation | 0.04% |
| 148 | Corcept Therapeutics Incorporated. | 0.04% |
| 149 | Ultragenyx Pharmaceutical, Inc. | 0.04% |
| 150 | Vaxcyte, Inc. | 0.04% |
| 151 | Evolent Health Inc Class A | 0.04% |
| 152 | Oak Street Health, Inc. | 0.04% |
| 153 | STAAR Surgical Company | 0.04% |
| 154 | 1Life Healthcare, Inc. | 0.04% |
| 155 | Pacific Biosciences of California, Inc. | 0.04% |
| 156 | Omnicell, Inc. | 0.04% |
| 157 | Glaukos Corp | 0.04% |
| 158 | Pacira Biosciences, Inc. | 0.04% |
| 159 | SAGE Therapeutics, Inc. | 0.04% |
| 160 | Axsome Therapeutics, Inc. | 0.04% |
| 161 | Allscripts Healthcare Solutions, Inc. | 0.03% |
| 162 | Tilray Brands, Inc. | 0.03% |
| 163 | Vir Biotechnology, Inc. | 0.03% |
| 164 | Prothena Corp. Plc | 0.03% |
| 165 | Signify Health, Inc. Class A | 0.03% |
| 166 | NuVasive, Inc. | 0.03% |
| 167 | AtriCure, Inc. | 0.03% |
| 168 | Veracyte Inc | 0.03% |
| 169 | Supernus Pharmaceuticals, Inc. | 0.03% |
| 170 | IVERIC bio, Inc. | 0.03% |
| 171 | Surgery Partners, Inc. | 0.03% |
| 172 | Embecta Corporation | 0.03% |
| 173 | ACADIA Pharmaceuticals Inc. | 0.03% |
| 174 | Silk Road Medical, Inc. | 0.03% |
| 175 | Privia Health Group, Inc. | 0.03% |
| 176 | Arvinas, Inc. | 0.03% |
| 177 | TransMedics Group, Inc. | 0.03% |
| 178 | Cerevel Therapeutics Holdings Inc | 0.03% |
| 179 | Addus HomeCare Corporation | 0.03% |
| 180 | Certara, Inc. | 0.03% |
| 181 | Revance Therapeutics, Inc. | 0.03% |
| 182 | Xenon Pharmaceuticals Inc. | 0.03% |
| 183 | Xencor, Inc. | 0.03% |
| 184 | Ironwood Pharmaceuticals, Inc. Class A | 0.03% |
| 185 | Maravai Lifesciences Holdings, Inc. Class A | 0.03% |
| 186 | Catalyst Pharmaceuticals, Inc. | 0.03% |
| 187 | Myriad Genetics, Inc. | 0.03% |
| 188 | Fate Therapeutics, Inc. | 0.03% |
| 189 | Nevro Corp. | 0.03% |
| 190 | Arcus Biosciences, Inc. | 0.03% |
| 191 | AdaptHealth Corp. | 0.03% |
| 192 | Dynavax Technologies Corporation | 0.02% |
| 193 | Owens & Minor, Inc. | 0.02% |
| 194 | Agios Pharmaceuticals, Inc. | 0.02% |
| 195 | CorVel Corporation | 0.02% |
| 196 | Twist Bioscience Corp. | 0.02% |
| 197 | Revolution Medicines, Inc. | 0.02% |
| 198 | Relay Therapeutics, Inc. | 0.02% |
| 199 | Harmony Biosciences Holdings, Inc. | 0.02% |
| 200 | Krystal Biotech, Inc. | 0.02% |
| 201 | Meridian Bioscience, Inc. | 0.02% |
| 202 | Celldex Therapeutics, Inc. | 0.02% |
| 203 | Phreesia, Inc. | 0.02% |
| 204 | Akero Therapeutics, Inc. | 0.02% |
| 205 | NeoGenomics, Inc. | 0.02% |
| 206 | Cassava Sciences, Inc. | 0.02% |
| 207 | R1 RCM Inc | 0.02% |
| 208 | Cross Country Healthcare, Inc. | 0.02% |
| 209 | Novavax, Inc. | 0.02% |
| 210 | FibroGen, Inc. | 0.02% |
| 211 | Pediatrix Medical Group, Inc. | 0.02% |
| 212 | Avanos Medical, Inc. | 0.02% |
| 213 | Establishment Labs Holdings, Inc. | 0.02% |
| 214 | Ligand Pharmaceuticals Incorporated | 0.02% |
| 215 | TG Therapeutics, Inc. | 0.02% |
| 216 | NextGen Healthcare, Inc. | 0.02% |
| 217 | Myovant Sciences Ltd. | 0.02% |
| 218 | Amphastar Pharmaceuticals, Inc. | 0.02% |
| 219 | Syndax Pharmaceuticals Inc | 0.02% |
| 220 | MannKind Corporation | 0.02% |
| 221 | Apollo Medical Holdings, Inc. | 0.02% |
| 222 | Alignment Healthcare, Inc. | 0.02% |
| 223 | U.S. Physical Therapy, Inc. | 0.02% |
| 224 | uniQure N.V. | 0.02% |
| 225 | Travere Therapeutics, Inc. | 0.02% |
| 226 | Rhythm Pharmaceuticals, Inc. | 0.02% |
| 227 | Reata Pharmaceuticals, Inc. Class A | 0.02% |
| 228 | Schrodinger, Inc. | 0.02% |
| 229 | DICE Therapeutics, Inc. | 0.02% |
| 230 | ImmunoGen, Inc. | 0.02% |
| 231 | Rocket Pharmaceuticals, Inc. | 0.02% |
| 232 | RadNet, Inc. | 0.02% |
| 233 | Zentalis Pharmaceuticals, Inc. | 0.02% |
| 234 | Kymera Therapeutics, Inc. | 0.02% |
| 235 | ModivCare Inc. | 0.02% |
| 236 | Avid Bioservices, Inc. | 0.02% |
| 237 | Vericel Corporation | 0.02% |
| 238 | CryoPort, Inc. | 0.02% |
| 239 | LeMaitre Vascular, Inc. | 0.02% |
| 240 | Chinook Therapeutics Inc | 0.02% |
| 241 | Mesa Laboratories, Inc. | 0.01% |
| 242 | National HealthCare Corporation | 0.01% |
| 243 | Kura Oncology, Inc. | 0.01% |
| 244 | Adaptive Biotechnologies Corp. | 0.01% |
| 245 | REGENXBIO, Inc. | 0.01% |
| 246 | Cytek Biosciences, Inc. | 0.01% |
| 247 | Atrion Corporation | 0.01% |
| 248 | Enanta Pharmaceuticals, Inc. | 0.01% |
| 249 | Outset Medical, Inc. | 0.01% |
| 250 | Allogene Therapeutics, Inc. | 0.01% |
| 251 | Varex Imaging Corporation | 0.01% |
| 252 | Madrigal Pharmaceuticals, Inc. | 0.01% |
| 253 | Innoviva, Inc. | 0.01% |
| 254 | Sotera Health Company | 0.01% |
| 255 | Keros Therapeutics, Inc. | 0.01% |
| 256 | Verve Therapeutics, Inc. | 0.01% |
| 257 | Iovance Biotherapeutics Inc | 0.01% |
| 258 | Viridian Therapeutics, Inc. | 0.01% |
| 259 | Alphatec Holdings, Inc. | 0.01% |
| 260 | OPKO Health, Inc. | 0.01% |
| 261 | 23andMe Holding Co. Class A | 0.01% |
| 262 | Cutera, Inc. | 0.01% |
| 263 | American Well Corporation Class A | 0.01% |
| 264 | Hims & Hers Health, Inc. Class A | 0.01% |
| 265 | Arcutis Biotherapeutics Inc | 0.01% |
| 266 | Editas Medicine, Inc. | 0.01% |
| 267 | Enhabit, Inc | 0.01% |
| 268 | Fulgent Genetics, Inc. | 0.01% |
| 269 | Collegium Pharmaceutical, Inc. | 0.01% |
| 270 | Aclaris Therapeutics, Inc. | 0.01% |
| 271 | Cerus Corporation | 0.01% |
| 272 | Inhibrx Inc | 0.01% |
| 273 | Anavex Life Sciences Corp. | 0.01% |
| 274 | CareDx, Inc. | 0.01% |
| 275 | Agenus Inc. | 0.01% |
| 276 | Crinetics Pharmaceuticals Inc | 0.01% |
| 277 | BioLife Solutions, Inc. | 0.01% |
| 278 | ImmunityBio Inc | 0.01% |
| 279 | Invitae Corp. | 0.01% |
| 280 | Springworks Therapeutics, Inc. | 0.01% |
| 281 | Heska Corporation | 0.01% |
| 282 | ViewRay, Inc. | 0.01% |
| 283 | Simulations Plus, Inc. | 0.01% |
| 284 | Seres Therapeutics Inc | 0.01% |
| 285 | Deciphera Pharmaceuticals, Inc. | 0.01% |
| 286 | BridgeBio Pharma, Inc. | 0.01% |
| 287 | OrthoPediatrics Corp. | 0.01% |
| 288 | HealthStream, Inc. | 0.01% |
| 289 | Theravance Biopharma Inc | 0.01% |
| 290 | Aurinia Pharmaceuticals Inc. | 0.01% |
| 291 | Vanda Pharmaceuticals Inc. | 0.01% |
| 292 | Pliant Therapeutics, Inc. | 0.01% |
| 293 | DocGo Inc. | 0.01% |
| 294 | Sorrento Therapeutics, Inc. | 0.01% |
| 295 | Bionano Genomics, Inc. | 0.01% |
| 296 | Morphic Holding, Inc. | 0.01% |
| 297 | 2seventy Bio, Inc. | 0.01% |
| 298 | Nuvalent, Inc. Class A | 0.01% |
| 299 | Cardiovascular Systems, Inc. | 0.01% |
| 300 | ADMA Biologics, Inc. | 0.01% |
| 301 | EQRx, Inc. | 0.01% |
| 302 | FIGS, Inc. Class A | 0.01% |
| 303 | Agiliti, Inc. | 0.01% |
| 304 | Emergent BioSolutions Inc. | 0.01% |
| 305 | Paragon 28, Inc. | 0.01% |
| 306 | Cara Therapeutics Inc | 0.01% |
| 307 | Accolade, Inc. | 0.01% |
| 308 | Brookdale Senior Living Inc. | 0.01% |
| 309 | Kiniksa Pharmaceuticals Ltd. Class A | 0.01% |
| 310 | Nektar Therapeutics | 0.01% |
| 311 | Castle Biosciences, Inc. | 0.01% |
| 312 | Artivion, Inc. | 0.01% |
| 313 | Inovio Pharmaceuticals, Inc. | 0.01% |
| 314 | Health Catalyst, Inc. | 0.01% |
| 315 | RAPT Therapeutics, Inc. | 0.01% |
| 316 | Immunovant Inc | 0.01% |
| 317 | Replimune Group, Inc. | 0.01% |
| 318 | AngioDynamics, Inc. | 0.01% |
| 319 | SurModics, Inc. | 0.01% |
| 320 | Intercept Pharmaceuticals, Inc. | 0.01% |
| 321 | Senseonics Holdings, Inc. | 0.01% |
| 322 | Inogen, Inc. | 0.01% |
| 323 | Altimmune, Inc. | 0.01% |
| 324 | Ventyx Biosciences, Inc. | 0.01% |
| 325 | PROCEPT BioRobotics Corp. | 0.01% |
| 326 | Sangamo Therapeutics, Inc. | 0.01% |
| 327 | Imago BioSciences, Inc. | 0.01% |
| 328 | Quanterix Corporation | 0.01% |
| 329 | AnaptysBio, Inc. | 0.01% |
| 330 | Alector, Inc. | 0.01% |
| 331 | Recursion Pharmaceuticals, Inc. Class A | 0.01% |
| 332 | Merus N.V. | 0.01% |
| 333 | Avidity Biosciences Inc | 0.01% |
| 334 | Arcturus Therapeutics Holdings, Inc. | 0.01% |
| 335 | Gossamer Bio, Inc. | 0.01% |
| 336 | Nurix Therapeutics, Inc. | 0.01% |
| 337 | Clover Health Investments Corp. Class A | 0.01% |
| 338 | Sana Biotechnology, Inc. | 0.01% |
| 339 | Eagle Pharmaceuticals, Inc. | 0.01% |
| 340 | POINT Biopharma Global Inc. | 0.01% |
| 341 | MaxCyte, Inc. | 0.01% |
| 342 | Prometheus Biosciences, Inc | 0.01% |
| 343 | Community Health Systems, Inc. | 0.01% |
| 344 | Coherus BioSciences, Inc. | 0.01% |
| 345 | ATAI Life Sciences N.V. | 0.01% |
| 346 | Cogent Biosciences, Inc. | 0.01% |
| 347 | SIGA Technologies Inc | 0.01% |
| 348 | Definitive Healthcare Corp. Class A | 0.01% |
| 349 | iTeos Therapeutics, Inc. | 0.01% |
| 350 | Treace Medical Concepts, Inc. | 0.01% |
| 351 | SomaLogic, Inc. Class A | 0.01% |
| 352 | Atara Biotherapeutics Inc | 0.01% |
| 353 | Butterfly Network, Inc. Class A | 0.01% |
| 354 | Tango Therapeutics, Inc. | 0.01% |
| 355 | SI-BONE, Inc. | 0.01% |
| 356 | Orthofix Medical, Inc. | 0.01% |
| 357 | Atea Pharmaceuticals, Inc. | 0.01% |
| 358 | OraSure Technologies, Inc. | 0.01% |
| 359 | OptimizeRx Corporation | 0.01% |
| 360 | Ocugen Inc | 0.01% |
| 361 | Adicet Bio Inc | 0.01% |
| 362 | GoodRx Holdings, Inc. Class A | 0.01% |
| 363 | Codexis, Inc. | 0.01% |
| 364 | MacroGenics, Inc. | 0.01% |
| 365 | Cano Health, Inc. Class A | 0.01% |
| 366 | NanoString Technologies, Inc. | 0.01% |
| 367 | PetIQ, Inc. Class A | 0.01% |
| 368 | Arcellx, Inc. | 0.01% |
| 369 | Repare Therapeutics Inc. | 0.00% |
| 370 | Protagonist Therapeutics, Inc. | 0.00% |
| 371 | Pennant Group Inc | 0.00% |
| 372 | Tarsus Pharmaceuticals, Inc. | 0.00% |
| 373 | OmniAb, Inc. | 0.00% |
| 374 | MultiPlan Corp Class A | 0.00% |
| 375 | Heron Therapeutics Inc | 0.00% |
| 376 | Fulcrum Therapeutics, Inc. | 0.00% |
| 377 | Vera Therapeutics, Inc. Class A | 0.00% |
| 378 | Phibro Animal Health Corporation Class A | 0.00% |
| 379 | Seer, Inc. Class A | 0.00% |
| 380 | Amneal Pharmaceuticals, Inc. Class A | 0.00% |
| 381 | HilleVax, Inc | 0.00% |
| 382 | MiMedx Group, Inc. | 0.00% |
| 383 | Erasca, Inc. | 0.00% |
| 384 | Nuvation Bio, Inc. Class A | 0.00% |
| 385 | Joint Corp | 0.00% |
| 386 | IGM Biosciences, Inc. | 0.00% |
| 387 | Quantum-Si Incorporated Class A | 0.00% |
| 388 | PMV Pharmaceuticals, Inc. | 0.00% |
| 389 | Cincor Pharma, Inc. | 0.00% |
| 390 | ALX Oncology Holdings, Inc. | 0.00% |
| 391 | CareMax, Inc. Class A | 0.00% |
| 392 | ZimVie Inc. | 0.00% |
| 393 | Humacyte, Inc. | 0.00% |
| 394 | Cullinan Oncology, Inc. | 0.00% |
| 395 | Phathom Pharmaceuticals, Inc. | 0.00% |
| 396 | Pulmonx Corp. | 0.00% |
| 397 | Entrada Therapeutics Inc | 0.00% |
| 398 | MeiraGTx Holdings Plc | 0.00% |
| 399 | Organogenesis Holdings, Inc. Class A | 0.00% |
| 400 | Monte Rosa Therapeutics, Inc. | 0.00% |
| 401 | NGM Biopharmaceuticals, Inc. | 0.00% |
| 402 | Vaxart, Inc. | 0.00% |
| 403 | Y-mAbs Therapeutics, Inc. | 0.00% |
| 404 | Foghorn Therapeutics, Inc. | 0.00% |
| 405 | Century Therapeutics, Inc. | 0.00% |
| 406 | Stoke Therapeutics, Inc. | 0.00% |
| 407 | Rigel Pharmaceuticals, Inc. | 0.00% |
| 408 | Aerovate Therapeutics, Inc. | 0.00% |
| 409 | PDL BioPharma, Inc. | 0.00% |
| 410 | Janux Therapeutics, Inc. | 0.00% |
| 411 | Akoya Biosciences Inc | 0.00% |
| 412 | Nautilus Biotechnolgy, Inc. | 0.00% |
| 413 | Sema4 Holdings Corp. Class A | 0.00% |
| 414 | Aveanna Healthcare Holdings Inc | 0.00% |
| 415 | Vanguard Cash Management Market Liquidity Fund | 0.00% |
| 416 | EQUITY OTHER | 0.00% |
VHTチャート・配当金・配当利回り
配当金
| 西暦 | Q1 | Q2 | Q3 | Q4 | Annual | 増配率 |
| 2004 | $0.00 | $0.00 | $0.00 | $0.13 | $0.13 | |
| 2005 | $0.00 | $0.00 | $0.00 | $0.39 | $0.39 | 300.0% |
| 2006 | $0.00 | $0.00 | $0.00 | $0.62 | $0.62 | 159.0% |
| 2007 | $0.00 | $0.00 | $0.00 | $0.82 | $0.82 | 132.3% |
| 2008 | $0.00 | $0.00 | $0.00 | $0.75 | $0.75 | 91.5% |
| 2009 | $0.00 | $0.00 | $0.00 | $1.49 | $1.49 | 198.7% |
| 2010 | $0.00 | $0.00 | $0.00 | $0.98 | $0.98 | 65.8% |
| 2011 | $0.00 | $0.00 | $0.00 | $1.05 | $1.05 | 107.1% |
| 2012 | $0.00 | $0.00 | $0.00 | $1.20 | $1.20 | 114.3% |
| 2013 | $0.00 | $0.00 | $0.00 | $1.14 | $1.14 | 95.0% |
| 2014 | $0.00 | $0.00 | $0.00 | $1.29 | $1.29 | 113.2% |
| 2015 | $0.00 | $0.00 | $1.14 | $0.48 | $1.62 | 125.6% |
| 2016 | $0.40 | $0.43 | $0.50 | $0.52 | $1.84 | 113.6% |
| 2017 | $0.44 | $0.50 | $0.52 | $0.57 | $2.02 | 109.8% |
| 2018 | $0.39 | $0.63 | $0.58 | $0.63 | $2.22 | 109.9% |
| 2019 | $1.11 | $1.16 | $0.63 | $0.72 | $3.62 | 163.1% |
| 2020 | $0.45 | $0.76 | $0.63 | $0.88 | $2.71 | 74.9% |
| 2021 | $0.64 | $0.70 | $0.89 | $0.82 | $3.04 | 112.2% |
| 2022 | $0.72 | $0.77 | $0.82 | $0.98 | $3.29 | 108.3% |
ぐりっと今回の発表は、この部分です。
まとめ
・VHTの2022年Q4は19.4％と増配。
・VHTは2022年通期では8.3％増配。
・株価は昨年度よりマイナス推移。
あわせて読みたい
【2022年×VT】今年最後の配当と成績を振り返る 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VTの2022年Q4（12月）の配当金が発表されました。 2022年Q…
雑談（サラリーマン投資家ぐりっと目線）
セクター別ETFでは唯一購入している銘柄。
数年前に1株購入しており経過を観察中。
売却予定はないが、購入予定はありません。
さらに下がるのであれば、長期的には購入も検討します。
関連記事：あわせて読みたい
バフェットがいうとおり、投資には三振はありません。
必ずしもバッターボックスに立たないといけないわけではありません。
ただしバッターボックスで立つ準備をしている人と準備をしていない人では大きな差がでます。
投資口座を開設していない人は、準備だけでも進めていきましょう。
あわせて読みたい
【2022年Q４】今年のVYMは最高な結果でした 本と投資は人を成長させるをコンセプトにしているブロガー、Youtuber、40代サラリーマン投資家ぐりっとです。 VYMの2022年Q4（12月）の配当は0.9745＄でした。（ブログ…
あわせて読みたい
【2022年11月/表あり】セクター別・配当貴族・配当王をまとめ 毎月の恒例企画の米国株投資の代表格ETF、配当貴族、配当王の成績についてまとめてみました。 短期投資、長期投資に限らず、どのような動きをしているかを知ることは非…
コメント